Time to seek further clarity in the molecular analysis of von Willebrand disease?

Thrombosis and Haemostasis

Volumn 102, Issue 1, 2009, Pages 175-177

  Favaloro, Emmanuel J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

AMINO ACID SUBSTITUTION; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LETTER; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE; VWF GENE;

DATABASES, GENETIC; GENETIC MARKERS; HEMATOLOGY; HUMANS; POLYMORPHISM, GENETIC; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 67749099428     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-02-0111     Document Type: Letter

References (14)

1. Lester W, Guilliatt A, Grundy P, et al. Is VWF R924Q a benign polymorphism, a marker of a null allele or a factor VIII-binding defect? The debate continues with results from the UKHCDO VWD study. Thromb Haemost 2008; 100: 716-718.
2. Cumming A, Grundy P, Keeney S, et al.; the UK Haemophilia Centre Doctors' Organisation. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006; 96: 630-641.
3. Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-121.
4. James PD, Paterson AD, Notley C, et al., and Association of Hemophilia Clinic Directors of Canada. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study. J Thromb Haemost 2006; 4: 783-792.
5. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood 2007; 109: 145-154.
6. Castaman G, Lethagen S, Federici AB, et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood 2008; 111: 3531-3539.
7. Millar CM, Riddell AF, Brown SA, et al. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations. Thromb Haemost 2008; 99: 916-924.
8. Favaloro EJ, Bonar R, Kershaw G, et al. (on behalf of the RCPA QAP in Haematology). Reducing errors in identification of von Willebrand disease: The experience of the Royal college of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 2006; 32: 505-513.
9. Sadler JE, Budde U, Eikenboom JC, et al.; Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-2114.
10. James P, Lillicrap D. The role of molecular genetics in diagnosing von Willebrand disease. Semin Thromb Hemost 2008; 34: 502-508.
11. Othman M, Favaloro EJ. Genetics of type 2B von Willebrand disease: "true 2B", "tricky 2B", or "not 2B". What are the modifiers of the phenotype? Semin Thromb Hemost 2008; 34: 520-531.
12. Casonato A, Sartorello F, Pontara E, et al. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis. Thromb Haemost 2007; 98: 1182-1187.
13. th February, 2009.
14. Corrales I, Ramírez L, Altisent C, et al. Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene. Thromb Haemost 2009; 101: 570-576.